Variant report
Variant | nsv613323 |
---|---|
Chromosome Location | chr9:9793285-9802058 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr9:9796904-9797116 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | EP300 | chr9:9798861-9798880 | Hela-S3 | cervix: | n/a | n/a |
3 | GTF2F1 | chr9:9795671-9795745 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | JUN | chr9:9796761-9797028 | HepG2 | liver: | n/a | chr9:9796897-9796910 |
5 | JUND | chr9:9796725-9797083 | HepG2 | liver: | n/a | n/a |
6 | MAX | chr9:9800581-9800781 | NB4 | blood: | n/a | chr9:9800665-9800675 |
7 | NFYA | chr9:9793263-9793443 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr9:9794800-9794807 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr9:9798694-9798695 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr9:9794683-9794807 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr9:9797634-9797646 | A549 | lung: | n/a | n/a |
12 | TCF7L2 | chr9:9801345-9801886 | HepG2 | liver: | n/a | n/a |
13 | TEAD4 | chr9:9800110-9800350 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KDM4C-10 | chr9:9800546-9800674 | ENSG00000230920 |
2 | lnc-KDM4C-10 | chr9:9799423-9799608 | ENSG00000230920 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230920 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574171756 | chr9:9794689-9794690 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs368514527 | chr9:9794695-9794696 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs542890072 | chr9:9794716-9794717 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs144577294 | chr9:9794718-9794719 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs59583349 | chr9:9794720-9794721 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs541000423 | chr9:9794758-9794759 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs113657703 | chr9:9794761-9794762 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs371475151 | chr9:9794793-9794794 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs370278040 | chr9:9794799-9794800 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs191729377 | chr9:9794800-9794801 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs559066296 | chr9:9795680-9795681 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572690729 | chr9:9795733-9795734 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs573313572 | chr9:9795742-9795743 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs10114232 | chr9:9795743-9795744 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs376480304 | chr9:9795744-9795745 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs538296221 | chr9:9796726-9796727 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs143204881 | chr9:9796735-9796736 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs568968322 | chr9:9796761-9796762 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs556631328 | chr9:9796791-9796792 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs138820666 | chr9:9796794-9796795 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs554772985 | chr9:9796795-9796796 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs142841324 | chr9:9796813-9796814 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs147260766 | chr9:9796821-9796822 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs554156255 | chr9:9796823-9796824 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs567071963 | chr9:9796889-9796890 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs535821722 | chr9:9796892-9796893 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs76553457 | chr9:9796898-9796899 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs140830787 | chr9:9796993-9796994 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs377278419 | chr9:9797004-9797005 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs141398171 | chr9:9797011-9797012 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs542022066 | chr9:9797015-9797016 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs10977986 | chr9:9797029-9797030 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs561956096 | chr9:9797041-9797042 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs10977987 | chr9:9797049-9797050 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs527934405 | chr9:9797063-9797064 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs547685452 | chr9:9797098-9797099 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs547341219 | chr9:9797107-9797108 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs141214159 | chr9:9797112-9797113 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs189768587 | chr9:9799417-9799418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371250465 | chr9:9799424-9799425 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs567796661 | chr9:9799438-9799439 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs113460807 | chr9:9799439-9799440 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs181604476 | chr9:9799451-9799452 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs561165813 | chr9:9799461-9799462 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs2296171 | chr9:9799476-9799477 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs146153795 | chr9:9799489-9799490 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs546682230 | chr9:9799520-9799521 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs567135849 | chr9:9799532-9799533 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs548752046 | chr9:9799548-9799549 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs369292440 | chr9:9799565-9799566 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9799400-9799800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr9:9799400-9799800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr9:9799400-9800800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr9:9799400-9801400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr9:9799600-9799800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:9799800-9800600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr9:9799800-9800800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr9:9799800-9801000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr9:9800600-9801600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr9:9800800-9801600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr9:9801000-9801600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |